Rheumatic Fever: How Streptococcal Throat Infection Triggers an Autoimmune Disease

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 321-331

  Guilherme, Luiza ^a   Kalil, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25444513808     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50026-0     Document Type: Chapter

References (82)

1. Lancefield RC Specific relationships of cell composition to biologic activity of hemolytic streptococci. Harvey Lectures 1941, 36:251-265.
2. Fishetti V Streptococcal M protein. Sci Am 1991, 264(6):32-39.
3. Wannamaker LW Differences between streptococcal infections of the throat and skin. (In two parts). N Engl J Med 1970, 282:23-31.
4. Wannamaker LW Differences between streptococcal infections of the throat and skin. (In two parts). N Engl J Med 1970, 282:78-85.
5. Stollerman GH The changing face of rheumatic fever in the 20th century. J Med Microbiol 1998, 47:1-3.
6. Shikhman AR, Cunningham MW Immunological mimicry between N-acetylβ-D-glucosamine and cytokeratin peptides. J Immunol 1994, 152:4375-4387.
7. Shikhman AR, Greenspan NS, Cunningham MW Cytokeratin peptide SFGSGFGGGY mimics N-acetylβ-D-glucosamine in reaction with antibodies and lectins and induces in vivo anti-carbohydrate antibody response. J Immunol 1994, 153:5593-5606.
8. Manjula BN, Fischetti VA Tropomyosin-like 7-residue periodicity in three immunologically distinct streptococcal M proteins and its implicatiopn for the antiphagocytic property of the molecule. J Exp Med 1980, 151:695-708.
9. Manjula BN, Trus BL, Fischetti VA Presence of two distinct regions in the coiled-coil structure of the streptococcal PepM5 protein: Relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci (USA) 1985, 82:1064-1068.
10. Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PMA, Assis RV, Pedra F, Neumann J, Goldberg A, Patarroyo ME, Pillegi F, Kalil J Human-infiltrating T cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995, 92:415-420.
11. Cheadle WR Harveian lectures on the various manifestations of the rheumatic state as exemplified in child-hood and early life. Lancet 1889, 371:821-827.
12. Wilson MG, Schweitzer M Pattern of hereditary susceptibility in rheumatic fever. Circulation 1954, 10:699-704.
13. Uchida IA Possible genectic factors in the etiology of rheumatic fever. Am J Hum Genet 1953, 5:61-69.
14. Taranta A, Torosdag S, Metrakos JD, Jegier W, Uchida I Rheumatic fever in monozigotic and dizigotic twins (abstract). Circulation 1959, 20:788.
15. Glynn IE, Holborow EJ Realation between blood groups, secretor status and susceptibility to rheumatic fever. Arthritis Rheum 1961, 4:203-207.
16. Patarroyo ME, Winchester RJ, Vejerano A, Gibofsky A, Chalem F, Zabriskie JB, Kunkel HG Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979, 278:173-174.
17. Ayoub EM The search for host determinants of susceptibility to rheumatic fever: the missing link. Circulation 1984, 69:197-201.
18. Gibofsky A, Khanna A, Suh E, Zabriskie JB The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J Rheumatol 1991, 18(suppl 30):1-13.
19. Zabriskie JB, Lavenchy D, Willians RC, Fu SM, Yeadon CA, Fotino M, Braun DG Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum 1985, 28(9):1047-1051.
20. Ayoub EM, Barrett DJ, MacLaren NK, Krischen JP Association of class II histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986, 77:2019-2026.
21. Anastasiou-Nana M, Anderson JL, Carquist JF, Nanas JN HLA DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J 1986, 112(5):992-997.
22. Rajapakse CNA, Halim K, Al-Orainey L, Al-Nozha M, Al-Aska AK A genetic marker for rheumatic heart disease. Br Heart J 1987, 58:659-662.
23. Jhinghan B, Mehra NK, Reddy KS, Taneja V, Vaidya MC, Bhatia ML HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease. Tissue Antigens 1986, 27:172-178.
24. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991, 83:1995-1998.
25. Weidebach W, Goldberg AC, Chiarella J, Guilherme L, Snitcowsky R, Pileggi F, Kalil J HLA class II antigens in Rheumatic Fever: analysis of the DR locus by RFLP and Oligotyping. Hum Immunol 1994, 40:253-258.
26. Guédez Y, Kotby A, El-Demellaway M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999, 99:2784-2790.
27. Visentainer JE, Pereira FC, Dalalio MM, Tsuneto LT, Donadio PR, Moliterno RA Association of HLA-DR7 with rheumatic fever in the Brazilian population. J Rheumatol 2000, 27(6):1518-1520.
28. Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ HLA-A, B, DR and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 1987, 76:259-261.
29. Olmez U, Turgay M, Ozenirler S, Tutkak H, Duzgun N, Duman M, Tokgoz G Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Rheumatol 1992, 22(2):49-52.
30. Donadi EA, Smith AG, Louzada-Junior P, Voltarelli JC, Nepom GT HLA class I and class II profiles of patients presenting RF with Sydenham's chorea. J Neurol 2000, 247(2):122-128.
31. Goldberg AC, Kalil J, Kotb M, et al. HLA and rheumatic fever: 12th International Histocompatibility Workshop study. HLA: Genectic Diversity of HLA; Functional and Medical Implication 1997, 413-418. EDK. D. Charron (Ed.).
32. Stollerman GH Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991, 61:113-142.
33. Calveti PA Autoantibodies in rheumatic fever. Proc Soc Exp Biol Med 1945, 60:379-381.
34. Kaplan MH, Suchy ML Immunological relation of streptococcal and tissue antigens II. Cross-reactions antisera to mammalian heart tissue with cell wall constituent of certain strains of group A streptococci. J Exp Med 1964, 119:643-650.
35. Kaplan MH, Svec KH Immunologic relation of streptococcal antibody cross-reactive with heart tissue: Association with streptococcal infection, rheumatic fever and glomerulonephritis. J Exp Med 1964, 119:651-666.
36. Cunningham MW Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 470-511.
37. Roberts S, Kosanke S, Dunn TS, Jankelow D, Duran CMG, Cunningham MW Pathogenic Mechanism in Rheumatic Carditis: Focus on Valvular Endothelium. J Infect Diseases 2001, 183:507-511.
38. Bathia R, Narula J, Reddy KS, Koicha M, Malaviya AN, Pothineni RB, Tandon R, Bathia ML Lymphocyte subsets in acute rheumatic fever and rheumatic heart disease. Clin Cardiol 1989, 12:34-38.
39. Bhatnagar PK, Nijhawan R, Prakash K T cell subsets in acute rheumatic fever, rheumatic heart disease and acute glomerulonephritis cases. Immunol Letters 1987, 15:217-219.
40. Mclaughin JF, Paterson PY, Hartz RS, Embury SH Rheumatic carditis: in vitro responses of peripheral blood leukocytes to heart and streptococcal antigens. Arthritis Rheum 1972, 15:600-608.
41. Read SE, Fischetti VA, Utermohlen V, Falk RE, Zabriskie JB Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest 1974, 54:439-450.
42. Meric N, Berkel AI Cellular immunity in children with acute rheumatic fever and rheumatic carditis. Pediatr Res 1979, 13:16-20.
43. Read SE, Reid HFM, Fischetti VA, Poon-King T, Ramkissoon R, McDowell M, Zabriskie JB Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J Clin Immunol 1986, 6(6):433-441.
44. Gray ED, Wannamaker LW, Ayoub E, El Kholy A Cellular immune responses to extracellular streptococcal products in rheumatic heart disease. J Clin Invest 1981, 68:665-671.
45. Gross WL, Schlaak M Modulation of Human lymphocyte functions by group A streptococci. Clin Immunol Immunopathol 1984, 32:234-247.
46. Dale JB, Simpson WA, Ofek I, Beachey E Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein. J Immunol 1981, 126:1499-1505.
47. Kotb M, Courtney HS, Dale JB, Beachey EH Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins. J Immunol 1989, 142:966-970.
48. Raizada V, Williams RC, Chopra P, Gopinath N, Prakash K, Sharma KB, Cherian KM, Panday S, Arora R, Nigam M, Zabriskie JB, Husby G Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cells antibodies. Am J Med 1983, 74:225-237.
49. Yoshinaga M, Figueiroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients. J Autoimmun 1995, 8:601-613.
50. Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S Molecular analysis of human cardiac myosin-cross-reactive B and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 1997, 65(9):3913-3923.
51. Guilherme L, Oshiro SE, Fae KC, Cunha-Neto E, Renesto G, Goldberg AC, Tanaka AC, Pomerantzeff P, Kiss MH, Silva C, Guzman F, Patarroyo ME, Southwood S, Sette A, Kalil J T cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immunity 2001, 69(9):5345-5535.
52. Manjula BN, Acharya AS, Mische MS, Fairwell T, Fischetti VA The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem 1984, 259:3686-3693.
53. Miller LC, Gray ED, Beachey EH, Kehoe MA Antigenic variation among group A streptococcal M proteins: nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. J Biol Chem 1988, 263:5668-5673.
54. Robinson JH, Atherton MC, Goodacre JÁ, Pinkney M, Weightman H, Kehoe MA Mapping T-cell epitopes in group A streptococcal type 5 M protein. Infect Immun 1991, 59(12):4324-4331.
55. El-Demellawy M, El-Ridi R, Guirguis NI, Alim MA, Kotby A, Kotb M Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect Immun 1997, 65(6):2197-2205.
56. Kotb M, Majumdar G, Tomai M, Beachey EH Accessory cell-independent stimulation of human T cells by streptococcal M protein superantigen. J Immunol 1990, 145:1332-1336.
57. Tomai M, Kotb M, Majumdar G, Beachey EH Superantigenicity of streptococcal M protein. J Exp Med 1990, 172:359-362.
58. Tomai MA, Schlievert PM, Kotb M Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 protein. Infect Immun 1992, 60:701-705.
59. Watanabe-Ohnishi R, Aelion J, Legros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M Characterization of unique human TCR Vb specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol 1994, 152:2066-2073.
60. Tomai MA, Aelion J, Dockter ME, Majumdar G, Spinella DG, Kotb M T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J Exp Med 1991, 174:285-288.
61. Wang B, Schlievert PM, Gaber AO, Kotb M Localization of an immunologically functional region of the streptococcal superantigen pepsin-extracted fragment of type 5 M protein. J Immunol 1993, 151:1419.
62. Degnan B, Taylor J, hawkes C, O'Shea U, Smith J, Robinson JH, Kehoe MA, Boylston A, Goodacre JÁ Streptococcus pyogenes type 5M protein is an antigen, not a superantigen, for human T cells. Hum Immunol 1997, 53:206-215.
63. Fleischer B, Schmidt KH, Gerlach D, Kohler W Separation of T cell stimulating activity from streptococcal M protein. Infect Immun 1992, 1:767-772.
64. Li PLL, Tiedemann RE, Moffat LS, Fraser JD The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med 1997, 186(3):375-391.
65. Guilherme L, Dulphy N, Douay C, Coelho V, Cunha-Neto E, Oshiro SE, Assis RV, Tanaka AC, Pomerantzeff PM, Charron D, Toubert A, Kalil J Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol 2000, 12:1063-1074.
66. Guilherme L, Cunha-Neto E, Tanaka AC, Dulphy N, Toubert A, Kalil J Heart-directed autoimmunity: the case of rheumatic fever. J Autoimmun 2001, 16:363-367.
67. Figueroa F, Gonzalez M, Carrion F, Lobos C, Turner F, Lasagna N, Valdes F Restriction in the usage of variable beta regions in T-cells infiltrating valvular tissue from rheumatic heart disease patients. J Autoimmun 2002, 19:233-240.
68. Faé K, Kalil J, Toubert A, Guilherme L Heart infiltrating T-cell clones from a rheumatic heart disease patient display a common TCR usage and a Degenerate antigen recognition pattern. Mol Immunol 2004, 40(14). in press.
69. Miller LC, Gray ED, Mansour M, Abdin ZH, Kamel R, Zaher S, Regelmann WE Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. J Rheumatol 1989, 16:1436-1442.
70. Morris K, Mohan C, wahi PL, Anand IS, Ganguly NK Enhancement of IL-1, Il-2 production and Il-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease: a prospecitive study. Clin Exp Immunol 1993, 91:429-436.
71. Narin N, Kütükçüler N, Özyürek R, Bakiler AR, Parlar A, Arcasoy M Lymphocyte subsets and plasma IL-1 α, IL-2, and TNFα concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 1995, 77:172-176.
72. Samsonov MY, Tilz GP, Pisklakov VP, Reibnegger G, Nassonov EL, Nassonova VA, Wachter H, Fuchs D Serum-soluble receptors for tumor necrosis factorα and interleukin-2 and neopterin in acute rheumatic fever. Clin Immunol Immunopathol 1995, 74:31-34.
73. Yegin O, Coskun M, Ertug H Cytokines in acute rheumatic fever. Eur J Pediatr 1997, 156:25-29.
74. Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989, 52:225-237.
75. Chopra P, Narula J, Kumar SA, Sachdeva S, Bathia ML Immunohistochemical characterization of Aschoff nodules and endomyocardial inflammatory infiltrates in left atrial appendages from patients with chronic rheumatic heart disease. Int J Cardiol 1988, 20:99-105.
76. Fraser WJ, Haffejee Z, Jankelow D, Wadee A, Cooper K Rheumatic Aschoff nodules revisited. II. Cytokine expression corroborates recently proposed sequential stages. Histopathology 1997, 31:460-464.
77. Williams RC Host factors in rheumatic fever and heart disease. Hosp Practice 1982, 125-138.
78. Dos Reis GA, Gaspar MIC, Barcinski MA Immune recognition in the streptococcal carditis of mice: the role of macrophages in the generation of heart-reactive lymphocytes. J Immunol 1982, 128:1514-1521.
79. Huber AS, Cunningham MW Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackieviral myocarditis. J Immunol 1996, 156:3528-3534.
80. Cunningham MW Molecular mimicry between group A streptococci and myosin in the pathogenesis of acute rheumatic fever. Rheumatic Fever 1999, 135-165. Eds American Registry of Pathology. J. Narula, R. Virmani, K.S. Reddy, R. Tandon (Eds.).
81. Quinn A, Kosanke SD, Fischetti VA, Factor SM, Cunningham M Induction of autoimmune valvular heart disease by recombinant streptococcal M protein. Infect Immun 2001, 69:4072-4078.
82. Galvin JE, Hemric ME, Kosanke SD, Factor SM, Quinn A, Cunningham M Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol 2002, 160(1):297-306.